This company has been marked as potentially delisted and may not be actively trading. Cyanotech (CYAN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesShort InterestTrendsBuy This Stock CYAN vs. HAPP, BON, SMFL, BFRG, CARM, CSCI, TNON, GOVX, BRTX, and LYRAShould you be buying Cyanotech stock or one of its competitors? The main competitors of Cyanotech include Happiness Development Group (HAPP), Bon Natural Life (BON), Smart for Life (SMFL), Bullfrog AI (BFRG), Carisma Therapeutics (CARM), COSCIENS Biopharma (CSCI), Tenon Medical (TNON), GeoVax Labs (GOVX), Biorestorative Therapies (BRTX), and Lyra Therapeutics (LYRA). Cyanotech vs. Its Competitors Happiness Development Group Bon Natural Life Smart for Life Bullfrog AI Carisma Therapeutics COSCIENS Biopharma Tenon Medical GeoVax Labs Biorestorative Therapies Lyra Therapeutics Happiness Development Group (NASDAQ:HAPP) and Cyanotech (NASDAQ:CYAN) are both small-cap medicinals & botanicals industry companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations. Do institutionals and insiders have more ownership in HAPP or CYAN? 15.2% of Happiness Development Group shares are held by institutional investors. Comparatively, 24.4% of Cyanotech shares are held by institutional investors. 15.6% of Happiness Development Group shares are held by insiders. Comparatively, 29.1% of Cyanotech shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media refer more to HAPP or CYAN? In the previous week, Happiness Development Group's average media sentiment score of 0.00 equaled Cyanotech'saverage media sentiment score. Company Overall Sentiment Happiness Development Group Neutral Cyanotech Neutral Which has better valuation and earnings, HAPP or CYAN? Cyanotech has lower revenue, but higher earnings than Happiness Development Group. Cyanotech is trading at a lower price-to-earnings ratio than Happiness Development Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHappiness Development Group$95.59M0.05-$49.19M$0.481.44Cyanotech$23.07M0.10-$5.27M-$0.66-0.48 Is HAPP or CYAN more profitable? Happiness Development Group has a net margin of 0.00% compared to Cyanotech's net margin of -19.50%. Happiness Development Group's return on equity of 0.00% beat Cyanotech's return on equity.Company Net Margins Return on Equity Return on Assets Happiness Development GroupN/A N/A N/A Cyanotech -19.50%-44.71%-19.12% Which has more volatility & risk, HAPP or CYAN? Happiness Development Group has a beta of 0.23, meaning that its share price is 77% less volatile than the S&P 500. Comparatively, Cyanotech has a beta of -0.11, meaning that its share price is 111% less volatile than the S&P 500. SummaryHappiness Development Group beats Cyanotech on 7 of the 11 factors compared between the two stocks. Get Cyanotech News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYAN vs. The Competition Export to ExcelMetricCyanotechMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.26M$3.50B$5.82B$9.77BDividend YieldN/AN/A4.40%4.06%P/E Ratio-0.488.6131.3026.05Price / Sales0.1055.23433.14108.31Price / CashN/A5.6238.0259.36Price / Book0.241.189.536.60Net Income-$5.27M$17.44M$3.26B$265.65M Cyanotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYANCyanotechN/A$0.32+5.3%N/A-58.4%$2.26M$23.07M-0.4895Gap DownHAPPHappiness Development GroupN/A$0.71-8.7%N/A-31.7%$4.95M$95.59M1.48215Gap UpBONBon Natural LifeN/A$1.30flatN/A-97.0%$217K$23.84M0.00100Gap DownSMFLSmart for LifeN/A$0.01+138.5%N/A-99.7%$44K$11.11M0.00110Gap UpBFRGBullfrog AI0.4048 of 5 stars$1.28+0.8%N/A-50.4%$11.96MN/A-1.584Positive NewsGap UpCARMCarisma Therapeutics2.9796 of 5 stars$0.28+1.6%$1.93+587.5%-79.1%$11.70M$19.63M-0.1820News CoverageShort Interest ↓CSCICOSCIENS BiopharmaN/A$3.56-0.6%N/AN/A$11.21M$9.59M-0.6120TNONTenon Medical1.5463 of 5 stars$1.47+6.5%$4.67+217.5%+175.9%$11.16M$3.28M-0.058GOVXGeoVax Labs1.8494 of 5 stars$0.70+2.8%$8.88+1,169.7%-87.9%$11.14M$3.95M-0.3510Short Interest ↑Gap UpBRTXBiorestorative Therapies2.536 of 5 stars$1.47+4.3%$18.00+1,124.5%-10.0%$11.03M$400K-1.007LYRALyra Therapeutics3.213 of 5 stars$6.75+1.2%$100.00+1,381.5%-53.6%$10.80M$1.53M-0.1150 Related Companies and Tools Related Companies HAPP Competitors BON Competitors SMFL Competitors BFRG Competitors CARM Competitors CSCI Competitors TNON Competitors GOVX Competitors BRTX Competitors LYRA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYAN) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredThe New Way Retirees Are Getting Paid Extra Every MonthBloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyanotech Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyanotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access